Osteoporosis
Longevity and Age Management
Drug 'proven to reduce' arthritis symptoms
The drug 5-Loxin has been proven to reduce the symptoms of osteoarthritis - or degenerative arthritis - following the results of a human study, it has been asserted. ... Continue Reading
Ultrasound exam could assess osteoporosis risk
Predicting if a woman has a high possibility of developing osteoporosis could be done with a simple ultrasound exam of the heel, a multicenter study has revealed. ... Continue Reading
Lack of awareness on osteoporosis risk
The common misconception surrounding osteoporosis is that it is merely a condition that affects older women as a normal part of the aging process. ... Continue Reading
Medication found to 'reduce acceleration of bone loss'
Researchers in Canada have discovered that antiresorptive medication could help reduce risk of hip fracture in older men and women. ... Continue Reading
TRT could benefit men over 60, study suggests
Testosterone replacement therapy (TRT) could help reduce the risk of men over the age of 60 developing the age and gender hormone-related disorder osteoporosis, a new study has found. ... Continue Reading
Researchers Urge Monitoring Of Bone Health During Chemotherapy
In laboratory tests on mice, researchers found that a medication often used to reduce toxic side effects of chemotherapy induced bone loss and helped tumors grow in bone. So the researchers at Washington University School of Medicine in St. Louis are recommending increased awareness of bone health during cancer treatments. The medication studied is a growth factor commonly used to help cancer patients recover healthy blood counts after chemotherapy, which can destroy white blood cells. Low levels of white blood cells leave patients susceptible to infection. ... Continue Reading
Men Face Rising Osteoporosis Risk
Though it's much more common in women,osteoporosis can strike men too, often with debilitating consequences. Until recently, male-oriented research into the disease lagged far behind that devoted to women. But with more men living longer, and with their rates of osteoporosis climbing as a result, studies of male risk have become more common. ... Continue Reading
Once-a-month osteoporosis drug works well
As a treatment for the bone-thinning disease osteoporosis, ibandronate (marketed as Boniva) can be given once a month, rather than daily, without any loss in effectiveness, according to a report in The Annals of the Rheumatic Diseases. In fact, in some cases, monthly dosing may be more effective. ... Continue Reading
Key regulator of bone cells linked to osteoporosis
New Haven, Conn. -- Scientists at the Yale School of Medicine identified a molecule in osteoclasts, IRAK-M, that is a key regulator of the loss of bone mass. Osteoclasts are cells that play a major role in the development and remodeling of bone. They originate from the fusion of macrophages and are important mediators of the loss of bone mass that leads to osteoporosis Osteoporosis is a serious problem worldwide: it is characterized by loss of bone density leading to fractures in response to relatively mild trauma. ... Continue Reading
Injection for Better Bones
Osteoporosis is a disease in which bones become fragile and are more likely to break. If not prevented or if it's left untreated, osteoporosis can progress painlessly until a bone breaks. These broken bones occur typically in the hip, spine, and wrist. Any bone can be affected, but the hip and spine are especially prone to fracture. ... Continue Reading
Subscribe to the EBN
The Longevity Newsletter
